Front Door Pharmacy, LLC dba Pure Pharmacy (Pure Pharmaceuticals) – FDA 483, Jun 7, 2021
An FDA inspection of Front Door Pharmacy, LLC dba Pure Pharmacy in Houston, TX, revealed critical deficiencies in aseptic processing and environmental controls. The firm failed to maintain adequate first-pass air, conduct proper media fills, and implement a viable environmental monitoring program. Additionally, issues included unvalidated sporicidal agents, poor cleanroom air quality, and inadequate handling of hazardous drugs, indicating significant risks to product quality and patient safety.
- Inspection date
- June 7, 2021
- Product type
- drugs
ID · cba29edc-1ce9-4c44-b85c-483c955b6b7b
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.